1. Home
  2. WGRX vs ELTX Comparison

WGRX vs ELTX Comparison

Compare WGRX & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGRX
  • ELTX
  • Stock Information
  • Founded
  • WGRX 2022
  • ELTX 2011
  • Country
  • WGRX United States
  • ELTX United States
  • Employees
  • WGRX N/A
  • ELTX N/A
  • Industry
  • WGRX Other Pharmaceuticals
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WGRX Health Care
  • ELTX Health Care
  • Exchange
  • WGRX Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • WGRX 111.0M
  • ELTX 121.7M
  • IPO Year
  • WGRX 2025
  • ELTX N/A
  • Fundamental
  • Price
  • WGRX $0.68
  • ELTX $11.04
  • Analyst Decision
  • WGRX
  • ELTX Strong Buy
  • Analyst Count
  • WGRX 0
  • ELTX 2
  • Target Price
  • WGRX N/A
  • ELTX $11.00
  • AVG Volume (30 Days)
  • WGRX 1.3M
  • ELTX 73.1K
  • Earning Date
  • WGRX 11-11-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • WGRX N/A
  • ELTX N/A
  • EPS Growth
  • WGRX N/A
  • ELTX N/A
  • EPS
  • WGRX N/A
  • ELTX N/A
  • Revenue
  • WGRX $36,738,599.00
  • ELTX N/A
  • Revenue This Year
  • WGRX N/A
  • ELTX N/A
  • Revenue Next Year
  • WGRX N/A
  • ELTX N/A
  • P/E Ratio
  • WGRX N/A
  • ELTX N/A
  • Revenue Growth
  • WGRX 82384.51
  • ELTX N/A
  • 52 Week Low
  • WGRX $0.62
  • ELTX $4.05
  • 52 Week High
  • WGRX $7.04
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • WGRX N/A
  • ELTX 51.83
  • Support Level
  • WGRX N/A
  • ELTX $10.65
  • Resistance Level
  • WGRX N/A
  • ELTX $11.26
  • Average True Range (ATR)
  • WGRX 0.00
  • ELTX 0.50
  • MACD
  • WGRX 0.00
  • ELTX -0.07
  • Stochastic Oscillator
  • WGRX 0.00
  • ELTX 39.46

About WGRX Wellgistics Health Inc. Common Stock

Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: